Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.71 [0.6-0.85],0.00023909009559058,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10,Interleukin-10,Wald ratio,1,0.74 [0.63-0.87],0.000264823286916574,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.41 [1.17-1.71],0.00042648466122696,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MDK,Midkine,Inverse variance weighted,4,1.22 [1.09-1.37],0.000444453966968375,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.12 [1.05-1.2],0.00141655262353378,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ELN,Elastin,Inverse variance weighted,2,1.43 [1.14-1.79],0.00193947718336748,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.9 [0.84-0.97],0.00328487090458377,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.94 [0.91-0.98],0.00351512397298154,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.13 [1.04-1.23],0.0035244293102181,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.07 [1.02-1.12],0.00355130014443809,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,11,1.08 [1.02-1.13],0.00369562155417661,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCN1,Ficolin-1,Inverse variance weighted,28,0.95 [0.91-0.98],0.00640562106742152,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,8,1.07 [1.02-1.13],0.00819045726563109,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.86 [0.77-0.96],0.00830189693790212,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.95 [0.91-0.99],0.00893419383938255,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.14 [1.03-1.26],0.00895049359185942,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.03 [1.01-1.05],0.00957601672769223,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.87 [0.78-0.97],0.0103775456715102,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.88 [0.8-0.97],0.0104994705414568,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.04 [1.01-1.07],0.0133318377294078,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS9,Galectin-9,Inverse variance weighted,26,1.05 [1.01-1.08],0.0157859641072049,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.05 [1.01-1.09],0.016685347413425,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.94 [0.89-0.99],0.0175135462540922,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.83-0.98],0.0184906774613121,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.08 [1.01-1.14],0.01875393862289,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.93-0.99],0.018818447014452,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.88 [0.79-0.98],0.0195379466655317,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.93 [0.88-0.99],0.0204777383153441,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSD,Cathepsin D,Inverse variance weighted,17,1.06 [1.01-1.11],0.0218870535329633,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWC2,Brorin,Inverse variance weighted,22,1.05 [1.01-1.1],0.0229518844952439,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPO,Erythropoietin,Inverse variance weighted,5,0.79 [0.65-0.97],0.023432344228538,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.03 [1-1.05],0.0296845388624743,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAN,Brevican core protein,Inverse variance weighted,3,0.92 [0.86-0.99],0.0298426172801121,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.8 [0.66-0.98],0.0309359579086748,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.92 [0.85-0.99],0.0316747818504897,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.9 [0.82-0.99],0.0332612541219026,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.14 [1.01-1.3],0.0348864388497706,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.06 [1-1.11],0.0360376431192423,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH6,Cadherin-6,Inverse variance weighted,29,1.03 [1-1.06],0.036985450441949,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMNB2,Lamin-B2,Wald ratio,1,0.64 [0.42-0.98],0.038768626923199,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.95 [0.91-1],0.0390471874925998,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.08 [1-1.15],0.0411272696935978,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.08 [1-1.17],0.042275440907469,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP13,Collagenase 3,Inverse variance weighted,2,0.71 [0.51-0.99],0.0424078300309648,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.97 [0.95-1],0.0427633022799833,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.06 [1-1.12],0.0428271936307346,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.09 [1-1.19],0.042990233826795,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.03 [1-1.07],0.043008689919899,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PKD2,Polycystin-2,Inverse variance weighted,3,0.6 [0.37-0.98],0.0430918973055646,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.05 [1-1.1],0.0441732087794406,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALB1,Calbindin,Inverse variance weighted,2,0.82 [0.67-1],0.0452168996749759,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPPC,C-type natriuretic peptide,Wald ratio,1,1.51 [1.01-2.27],0.0468105494114539,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,1.18 [1-1.38],0.0471772799328757,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.93 [0.87-1],0.0474334722977838,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.21 [1-1.45],0.0496306930409056,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [1-1.05],0.0498645735929821,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.05 [1-1.1],0.0500909024789833,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LCP1,Plastin-2,Inverse variance weighted,18,1.03 [1-1.07],0.0507717760816166,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.95 [0.9-1],0.0513952987510248,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MPO,Myeloperoxidase,Inverse variance weighted,11,0.95 [0.9-1],0.0524959286592021,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.87 [0.76-1],0.0536574001969129,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSLN,Mesothelin,Inverse variance weighted,25,1.03 [1-1.06],0.0543335614857998,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.16 [1-1.35],0.0549762957346904,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.84 [0.7-1],0.0555610508656474,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.89 [0.78-1],0.05603614037324,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.66 [0.43-1.02],0.058904567981091,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.96 [0.92-1],0.0591008729018933,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.85 [0.72-1.01],0.0598856493134165,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.04 [1-1.08],0.0631164690208993,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MUC13,Mucin-13,Inverse variance weighted,9,1.08 [1-1.18],0.0640631802430119,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.94 [0.89-1],0.0659138008122671,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS4,Galectin-4,Inverse variance weighted,4,0.89 [0.79-1.01],0.0697498034490232,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.97 [0.94-1],0.0736951547624541,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,1.09 [0.99-1.2],0.0737495737745037,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.87 [0.76-1.01],0.0738228572395531,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.12 [0.99-1.27],0.0753597509509128,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.04 [1-1.09],0.075608958309585,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.19 [0.98-1.44],0.0758693414403775,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.16 [0.98-1.38],0.0765891331555097,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [1-1.03],0.0772730440751892,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL8,Interleukin-8,Inverse variance weighted,6,1.13 [0.99-1.29],0.080255147035455,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO1,R-spondin-1,Inverse variance weighted,5,1.06 [0.99-1.14],0.0803195372801886,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.07 [0.99-1.16],0.0807614685146996,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.2 [0.98-1.48],0.0839425013821775,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.03 [1-1.08],0.0860332513642702,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.05 [0.99-1.12],0.0862373386693659,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.03 [1-1.06],0.0867655777102297,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.02 [1-1.05],0.0893387989401513,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C7,Complement component C7,Inverse variance weighted,38,1.02 [1-1.04],0.0906150561014957,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [1-1.05],0.0923545003949609,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.96 [0.92-1.01],0.0937328094439192,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.9 [0.79-1.02],0.0952364244672735,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.13 [0.98-1.3],0.0958333840014799,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.02 [1-1.05],0.0982985831521859,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TMSB10,Thymosin beta-10,Wald ratio,1,0.78 [0.58-1.05],0.0988905088625076,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,1.05 [0.99-1.11],0.0995778734060345,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,0.87 [0.74-1.03],0.102206650442439,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.97 [0.94-1.01],0.102442244498463,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.89 [0.77-1.02],0.105377918283203,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.95 [0.88-1.01],0.112302549304935,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC1,Syndecan-1,Inverse variance weighted,2,1.1 [0.98-1.25],0.115282933312156,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OCLN,Occludin,Inverse variance weighted,2,0.9 [0.79-1.03],0.116331182999921,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.99-1.05],0.116427087022482,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.02 [0.99-1.05],0.11822384272155,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.03 [0.99-1.07],0.118332409666391,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.04 [0.99-1.08],0.118648707010261,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS1,Galectin-1,Inverse variance weighted,6,0.96 [0.91-1.01],0.120045317552758,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.93 [0.86-1.02],0.120271523949529,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.93-1.01],0.123525754394103,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.91 [0.81-1.03],0.124410684289414,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.07 [0.98-1.17],0.124489565028528,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.03 [0.99-1.07],0.125349385318802,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.03 [0.99-1.06],0.127983331995299,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.97 [0.93-1.01],0.133117982415305,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,F11R,Junctional adhesion molecule A,Wald ratio,1,1.24 [0.94-1.64],0.134447171437809,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MANSC4,MANSC domain-containing protein 4,Inverse variance weighted,32,1.02 [0.99-1.05],0.136322444819531,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.02 [0.99-1.05],0.137407585835765,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.11 [0.97-1.29],0.137633104992269,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCAN,Neurocan core protein,Inverse variance weighted,3,1.09 [0.97-1.22],0.137924816301674,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.98 [0.95-1.01],0.13933404738082,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,1.11 [0.97-1.27],0.139424944352499,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,0.94 [0.87-1.02],0.139745007927194,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.03 [0.99-1.08],0.139839484444699,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.98 [0.94-1.01],0.142826032261662,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,7,0.95 [0.89-1.02],0.143501467318409,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.03 [0.99-1.07],0.146520833677725,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.01 [1-1.03],0.147974500513244,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN1,Contactin-1,Inverse variance weighted,22,0.96 [0.92-1.01],0.148554735869018,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.04 [0.99-1.09],0.149295195237243,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.05 [0.98-1.11],0.150309138179863,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,1.05 [0.98-1.12],0.150996581390082,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.92 [0.82-1.03],0.151235634440948,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.96 [0.92-1.01],0.15161620650944,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.09 [0.97-1.21],0.151962866491535,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PI3,Elafin,Inverse variance weighted,10,1.04 [0.99-1.09],0.153678681152593,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG2,Secretogranin-2,Wald ratio,1,1.3 [0.91-1.86],0.153987693833359,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.12 [0.96-1.31],0.155492872366278,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.02 [0.99-1.04],0.155853493112708,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FETUB,Fetuin-B,Inverse variance weighted,20,0.97 [0.94-1.01],0.156021050122678,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.09 [0.97-1.24],0.159385210454564,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.97 [0.92-1.01],0.159971148754922,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.97 [0.93-1.01],0.160538010989189,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.03 [0.99-1.07],0.161686322235762,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.05 [0.98-1.12],0.162079290086154,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.97 [0.94-1.01],0.162089542375157,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.02 [0.99-1.06],0.16363185321325,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.41 [0.87-2.28],0.169006369448238,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.96 [0.9-1.02],0.171827067066659,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.04 [0.98-1.1],0.175224702133728,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMBP,Protein AMBP,Inverse variance weighted,3,1.08 [0.97-1.21],0.175249611969759,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.96 [0.91-1.02],0.176180088880578,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.96-1.01],0.176745110830007,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.96 [0.89-1.02],0.177190466999508,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.96 [0.89-1.02],0.178014009035166,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.04 [0.98-1.1],0.179534610987601,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.95 [0.88-1.02],0.180130518229115,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [0.99-1.06],0.180175972267556,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.99-1.07],0.183148281829953,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,1.16 [0.93-1.45],0.185600801886612,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.97 [0.93-1.02],0.188905885703548,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.98-1.09],0.1890151716565,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.05 [0.97-1.14],0.193744697748841,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.94 [0.86-1.03],0.193846550530769,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.75 [0.48-1.16],0.194817705734504,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PYY,Peptide YY,Inverse variance weighted,6,1.05 [0.98-1.13],0.196065447857343,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBD,Thrombomodulin,Inverse variance weighted,5,1.06 [0.97-1.15],0.197741870151984,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.07 [0.96-1.19],0.198222736056582,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.19 [0.91-1.56],0.198498136554788,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.93 [0.84-1.04],0.198617659188204,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL14,C-X-C motif chemokine 14,Wald ratio,1,1.25 [0.89-1.77],0.198899779554405,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS3,Galectin-3,Inverse variance weighted,25,1.03 [0.98-1.09],0.199205971792417,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,1.13 [0.94-1.36],0.201144546340504,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.03 [0.99-1.07],0.206174092713507,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.02 [0.99-1.06],0.208604639518659,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP2,Retinol-binding protein 2,Wald ratio,1,1.2 [0.9-1.58],0.209168975072742,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,0.96 [0.91-1.02],0.209641678155047,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOA2,Apolipoprotein A-II,Wald ratio,1,0.85 [0.66-1.1],0.211396442144054,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.96 [0.9-1.02],0.211627457746165,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PSAP,Prosaposin,Inverse variance weighted,5,0.93 [0.84-1.04],0.214001098023727,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.97 [0.92-1.02],0.214784321080129,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANXA5,Annexin A5,Inverse variance weighted,2,0.9 [0.77-1.06],0.215048454352362,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.96-1.01],0.216251531391838,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS8,Prostasin,Inverse variance weighted,5,1.12 [0.94-1.33],0.216988093657231,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.99 [0.96-1.01],0.220854124594967,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.03 [0.98-1.08],0.221522145197907,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.02 [0.99-1.07],0.228796655068031,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,0.97 [0.92-1.02],0.229654670573493,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.93-1.02],0.230732196318986,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.97 [0.91-1.02],0.230798002491662,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAN,Aggrecan core protein,Inverse variance weighted,3,1.1 [0.94-1.29],0.231361001699635,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.93-1.02],0.235165878193849,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.97 [0.93-1.02],0.235230513398172,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.97 [0.91-1.02],0.235446800128025,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MVK,Mevalonate kinase,Inverse variance weighted,2,0.89 [0.74-1.08],0.236772283472949,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD46,Membrane cofactor protein,Wald ratio,1,1.12 [0.93-1.36],0.237425848867164,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.12 [0.93-1.36],0.237657180931043,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.96 [0.9-1.03],0.239119451355372,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CIT,Citron Rho-interacting kinase,Inverse variance weighted,2,1.18 [0.89-1.55],0.243117392157116,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.14 [0.91-1.43],0.243592425833661,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.85 [0.65-1.12],0.244606640037565,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM2,Paralemmin-2,Inverse variance weighted,8,1.04 [0.97-1.12],0.248591832914906,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,19,1.03 [0.98-1.07],0.248834733712834,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1.02 [0.98-1.06],0.249670338691211,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.97 [0.91-1.02],0.251649900481891,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COMP,Cartilage oligomeric matrix protein,Inverse variance weighted,5,1.06 [0.96-1.16],0.253418844836683,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.07 [0.96-1.19],0.254599571721118,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,31,0.98 [0.95-1.01],0.254671565241627,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.97 [0.93-1.02],0.256793846563892,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLIN3,Perilipin-3,Wald ratio,1,1.15 [0.91-1.45],0.257120549403006,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,1.04 [0.97-1.11],0.258603487579636,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.98 [0.94-1.02],0.260479512514733,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.98-1.07],0.261705763536193,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.89 [0.73-1.09],0.263251222789837,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100P,Protein S100-P,Inverse variance weighted,2,0.88 [0.69-1.1],0.263552626532814,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.95 [0.86-1.04],0.264399273208216,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.02 [0.98-1.06],0.265239446116518,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,0.96 [0.9-1.03],0.266260904152701,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.06 [0.96-1.16],0.267286359318011,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [0.99-1.05],0.271013042807812,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEPTIN8,Septin-8,Inverse variance weighted,2,1.07 [0.95-1.21],0.273241400069355,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RETN,Resistin,Inverse variance weighted,9,0.98 [0.95-1.02],0.274218597147799,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.94 [0.85-1.05],0.274368657686365,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSV,Cathepsin L2,Inverse variance weighted,11,1.03 [0.97-1.1],0.275579949359034,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.07 [0.95-1.21],0.275818210392887,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.96 [0.9-1.03],0.277067553694859,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.96 [0.9-1.03],0.277208373359956,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FBLN2,Fibulin-2,Inverse variance weighted,11,0.97 [0.93-1.02],0.278352984143229,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.1 [0.93-1.3],0.279899406513499,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.98 [0.96-1.01],0.281322548065426,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,1.02 [0.98-1.06],0.282464486536499,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYBPC2,"Myosin-binding protein C, fast-type",Wald ratio,1,1.27 [0.82-1.98],0.285063629692652,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.9 [0.75-1.09],0.28507900315892,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.05 [0.96-1.14],0.28599973649722,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.99-1.04],0.287056620498179,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KYNU,Kynureninase,Inverse variance weighted,8,0.95 [0.87-1.04],0.290470394284944,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GHRL,Appetite-regulating hormone,Inverse variance weighted,3,1.02 [0.98-1.06],0.293309683725379,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.99 [0.97-1.01],0.296507137583889,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.94 [0.85-1.05],0.298214064025969,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.94 [0.84-1.06],0.298494593237755,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.96 [0.89-1.04],0.301336352704837,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD27,CD27 antigen,Inverse variance weighted,9,1.03 [0.98-1.08],0.30309210287944,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.13 [0.89-1.44],0.303195245353568,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,1.01 [0.99-1.04],0.305075888704939,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.96 [0.89-1.04],0.30530043487042,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CBLN4,Cerebellin-4,Inverse variance weighted,11,0.96 [0.9-1.03],0.308545212599465,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BSG,Basigin,Wald ratio,1,1.07 [0.94-1.21],0.308713466446369,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AREG,Amphiregulin,Inverse variance weighted,3,0.94 [0.85-1.05],0.309859651455023,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.03 [0.98-1.08],0.310314809245495,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,0.98 [0.95-1.02],0.312840990469117,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1.01 [0.99-1.04],0.313769930726826,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.07 [0.94-1.21],0.31459620958105,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.95 [0.85-1.05],0.316717208642276,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,1.05 [0.96-1.14],0.31821481630157,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSL,Cathepsin L1,Wald ratio,1,1.21 [0.83-1.75],0.320855915799356,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGF,Placenta growth factor,Inverse variance weighted,2,1.25 [0.8-1.95],0.322439066002873,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,0.98 [0.95-1.02],0.326475393140454,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN2,Nectin-2,Inverse variance weighted,5,1.05 [0.95-1.15],0.327358518626046,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.93 [0.81-1.07],0.327820807174187,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.81 [0.53-1.24],0.331193775952709,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.98 [0.93-1.02],0.334823494591468,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.98 [0.95-1.02],0.341941927185899,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.91 [0.74-1.11],0.343033365180768,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGES2,Prostaglandin E synthase 2,Wald ratio,1,1.15 [0.86-1.53],0.343646435432878,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAN,Versican core protein,Inverse variance weighted,31,0.98 [0.95-1.02],0.344832683067921,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.97-1.09],0.347508187876809,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.91 [0.75-1.11],0.348098242820597,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.03 [0.97-1.08],0.349551688613835,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.98-1.06],0.351815175085498,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,36,0.99 [0.96-1.01],0.353782094186955,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG3,Secretogranin-3,Inverse variance weighted,32,0.98 [0.95-1.02],0.355719182119345,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGRN,Agrin,Inverse variance weighted,17,1.03 [0.97-1.08],0.356080693357319,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,5,0.96 [0.88-1.05],0.356156819733904,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN5,CCN family member 5,Inverse variance weighted,8,0.94 [0.82-1.07],0.356279596195197,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.02 [0.98-1.06],0.357680221381075,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.04 [0.95-1.15],0.358261211147041,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.05 [0.95-1.16],0.358799823348503,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.88 [0.66-1.16],0.360646480272187,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLGN,Calmegin,Inverse variance weighted,23,0.98 [0.95-1.02],0.362335738621045,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.95 [0.86-1.06],0.367252004841719,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.2 [0.81-1.77],0.368350394617144,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGB,Secretogranin-1,Inverse variance weighted,27,1.01 [0.98-1.04],0.368812863976166,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC4,Syndecan-4,Inverse variance weighted,8,0.96 [0.89-1.04],0.369226718288152,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,0.99 [0.96-1.02],0.370922875861631,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.95-1.02],0.371152997425505,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN3,Matrilin-3,Inverse variance weighted,28,1.02 [0.98-1.07],0.375191583207718,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.78 [0.45-1.35],0.375505886377999,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.02 [0.97-1.08],0.375765864300245,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.02 [0.97-1.07],0.377486773317305,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO3,R-spondin-3,Inverse variance weighted,6,1.04 [0.95-1.14],0.379186795687799,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH1,Cadherin-1,Wald ratio,1,1.18 [0.82-1.7],0.3800969957073,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.01 [0.99-1.04],0.381158860734436,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.09 [0.9-1.3],0.381344634892253,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.23 [0.77-1.96],0.382254438634082,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.02 [0.97-1.07],0.3831734306236,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN2,Contactin-2,Inverse variance weighted,29,0.99 [0.96-1.02],0.383208369028662,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REN,Renin,Inverse variance weighted,4,1.03 [0.97-1.09],0.389651765436575,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.96-1.02],0.390359095444699,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.02 [0.97-1.08],0.39056434544983,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSO,Cathepsin O,Inverse variance weighted,6,1.03 [0.96-1.12],0.392977155585909,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS2,Trypsin-2,Inverse variance weighted,3,0.95 [0.86-1.06],0.39565455309026,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.96-1.01],0.400850755491734,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.02 [0.98-1.07],0.401113554321011,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.89 [0.67-1.17],0.403546595197562,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.03 [0.96-1.09],0.404105958428033,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.98 [0.94-1.03],0.404222543435872,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.99 [0.96-1.02],0.405104521238678,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.97 [0.89-1.05],0.409361350716671,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.03 [0.97-1.09],0.409505828121069,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.93 [0.78-1.11],0.411672207459405,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Wald ratio,1,1.03 [0.96-1.12],0.417223059741749,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.11 [0.86-1.43],0.417678342185685,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP6,Gastrotropin,Wald ratio,1,1.05 [0.93-1.2],0.418241580422288,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,6,1.04 [0.94-1.15],0.418984649295068,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.02 [0.98-1.05],0.419693463131518,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.94 [0.8-1.1],0.420230882157892,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCOF1,Treacle protein,Wald ratio,1,0.87 [0.63-1.22],0.420740558575324,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.94-1.03],0.422628800783134,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.85 [0.57-1.27],0.423405947037437,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAP2,Microtubule-associated protein 2,Wald ratio,1,1.24 [0.74-2.07],0.423923631622802,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN4,Nectin-4,Inverse variance weighted,7,1.02 [0.97-1.09],0.427322378202511,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.11 [0.86-1.45],0.427593285075287,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.92 [0.73-1.14],0.429662750582719,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD302,CD302 antigen,Inverse variance weighted,9,0.97 [0.89-1.05],0.431292962994311,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FST,Follistatin,Inverse variance weighted,4,0.96 [0.87-1.06],0.438054551206308,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.02 [0.97-1.08],0.438072199967649,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.03 [0.95-1.12],0.440561442111673,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,9,1.02 [0.98-1.06],0.440602006170268,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POMC,Pro-opiomelanocortin,Inverse variance weighted,2,0.87 [0.61-1.24],0.440690953622708,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,0.98 [0.94-1.03],0.44085009560484,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MB,Myoglobin,Wald ratio,1,1.19 [0.76-1.87],0.44407300334497,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFD,Complement factor D,Inverse variance weighted,11,1.02 [0.97-1.08],0.447792693278296,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGA,Chromogranin-A,Inverse variance weighted,3,1.03 [0.95-1.13],0.449109379481122,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.96 [0.87-1.06],0.451020424940924,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.01 [0.98-1.05],0.451271987253052,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.09 [0.86-1.39],0.451970284451807,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.98 [0.92-1.04],0.452296524139199,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.02 [0.97-1.08],0.452960990459845,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAYN,Layilin,Inverse variance weighted,20,0.98 [0.92-1.04],0.454787309981889,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.03 [0.96-1.1],0.455624241015204,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.06 [0.92-1.22],0.456815066297045,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN5,Contactin-5,Inverse variance weighted,28,1.01 [0.98-1.04],0.459447679140096,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.92 [0.74-1.14],0.45956252059034,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.02 [0.97-1.08],0.46022202448437,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.02 [0.97-1.07],0.460517167622437,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KITLG,Kit ligand,Wald ratio,1,1.13 [0.81-1.59],0.460973799939287,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.89-1.05],0.4613831429269,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.94-1.03],0.463344216080511,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP1,Interstitial collagenase,Inverse variance weighted,31,0.99 [0.96-1.02],0.46335628414661,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.05 [0.93-1.19],0.464914660403266,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.06 [0.91-1.22],0.464921052563144,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.08 [0.88-1.33],0.465349780194207,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.95 [0.82-1.1],0.467954873861905,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCTN3,Tectonic-3,Inverse variance weighted,33,1.01 [0.98-1.04],0.469212648966319,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.06 [0.9-1.24],0.469617070584716,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.1 [0.84-1.44],0.474175966075459,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15,Interleukin-15,Wald ratio,1,1.76 [0.37-8.27],0.475849690819388,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRH,Corticoliberin,Inverse variance weighted,11,0.98 [0.94-1.03],0.475870826236834,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.01 [0.98-1.05],0.478212538528574,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.95 [0.83-1.09],0.479711214555565,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.02 [0.97-1.07],0.48026610831611,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,0.97 [0.88-1.06],0.480343812484334,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.92 [0.74-1.15],0.480634221390885,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.97-1.07],0.482387438406937,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FUOM,Fucose mutarotase,Inverse variance weighted,3,0.95 [0.81-1.1],0.483168409804148,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.99 [0.96-1.02],0.486148076358735,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.13 [0.8-1.61],0.487689607345312,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.03 [0.95-1.11],0.489423514137684,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN2,Matrilin-2,Inverse variance weighted,18,0.98 [0.93-1.04],0.4897398537271,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.05 [0.92-1.19],0.490370105009616,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.04 [0.94-1.15],0.490479657723819,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.02 [0.97-1.07],0.494194637027088,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOMO1,Nodal modulator 1,Inverse variance weighted,2,0.95 [0.82-1.1],0.494649025676158,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.08 [0.87-1.34],0.495628512676117,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.98 [0.92-1.04],0.497917249837171,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.97 [0.9-1.05],0.498251862426116,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.03 [0.95-1.12],0.499151729802335,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.95-1.02],0.499651661999039,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.96 [0.86-1.08],0.499745230890659,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH2,Cadherin-2,Inverse variance weighted,3,0.94 [0.79-1.12],0.500534042214748,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.98 [0.93-1.04],0.50213519580091,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.96 [0.85-1.08],0.502553774004729,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.07 [0.87-1.32],0.502672677715129,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.02 [0.96-1.08],0.503518116471001,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.99 [0.97-1.01],0.504731040742898,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PXN,Paxillin,Inverse variance weighted,26,0.99 [0.96-1.02],0.507791042851275,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.03 [0.94-1.13],0.514116691151988,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.97 [0.89-1.06],0.516314531072613,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.01 [0.98-1.04],0.519447509528776,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,0.99 [0.96-1.02],0.520999071589702,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FURIN,Furin,Wald ratio,1,0.97 [0.88-1.07],0.523190849223648,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.11 [0.81-1.51],0.526552484205738,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,0.85 [0.52-1.4],0.526676457909653,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.98 [0.94-1.03],0.528334644106103,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.98 [0.93-1.04],0.528613198173687,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.01 [0.97-1.05],0.531084496885533,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.88 [0.6-1.31],0.531606924586438,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINB8,Serpin B8,Inverse variance weighted,28,0.99 [0.97-1.02],0.533680002088438,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,0.98 [0.92-1.04],0.537184261649498,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.97 [0.86-1.08],0.537270143475718,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.13 [0.76-1.69],0.540864759579738,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.02 [0.96-1.07],0.542562128917546,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.97 [0.88-1.07],0.543045242884237,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.01 [0.97-1.05],0.545618550285962,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.98 [0.93-1.04],0.548333479833615,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.01 [0.98-1.03],0.552415888066076,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.01 [0.97-1.05],0.559426811333932,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CELA2A,Chymotrypsin-like elastase family member 2A,Inverse variance weighted,4,1.06 [0.86-1.31],0.562738848799327,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.97 [0.88-1.07],0.56400425939329,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.94 [0.77-1.16],0.564210570917777,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.75-1.17],0.565965294380892,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.98 [0.9-1.06],0.568469233695718,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON2,Spondin-2,Inverse variance weighted,4,1.02 [0.95-1.1],0.568633332169529,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.04 [0.91-1.18],0.569124690837652,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.98 [0.92-1.05],0.57162449770725,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DRAXIN,Draxin,Inverse variance weighted,13,0.99 [0.94-1.04],0.572563331220429,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPT,Dermatopontin,Inverse variance weighted,21,0.99 [0.94-1.04],0.578434080059677,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.92 [0.69-1.23],0.579619670387329,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP3,Stromelysin-1,Inverse variance weighted,34,1.01 [0.97-1.05],0.580890624509715,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGMN,Legumain,Inverse variance weighted,12,0.98 [0.93-1.04],0.581186974183849,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,0.99 [0.94-1.04],0.588586282512188,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.02 [0.94-1.11],0.589966930624317,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.99 [0.94-1.03],0.590838483078874,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,0.99 [0.97-1.02],0.592547137988867,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,0.99 [0.95-1.03],0.594029354810944,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.98-1.01],0.594320222066351,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.01 [0.97-1.06],0.596272376099696,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.97-1.02],0.597503650529931,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.01 [0.97-1.06],0.599315810146554,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.97 [0.86-1.09],0.599612864609858,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.99 [0.97-1.02],0.599722172483666,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.08 [0.81-1.43],0.601924928515758,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.11 [0.74-1.67],0.606416558663518,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR15L,Protein GPR15L,Inverse variance weighted,9,1.01 [0.96-1.07],0.607783898499138,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.98 [0.91-1.06],0.608699542244197,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.98 [0.91-1.06],0.61040628211345,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON1,Spondin-1,Inverse variance weighted,21,0.99 [0.94-1.04],0.610456987257887,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,3,0.97 [0.85-1.1],0.610466460636064,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.01 [0.97-1.06],0.61204096944135,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,0.96 [0.84-1.11],0.612697113896496,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.97 [0.87-1.09],0.616565506326289,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.99 [0.94-1.04],0.617838788529239,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.98 [0.93-1.05],0.620458280696887,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.04 [0.89-1.21],0.621094080095085,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,1.01 [0.98-1.04],0.623912257631361,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.96 [0.79-1.15],0.624021910648973,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.97 [0.88-1.08],0.624560823817753,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.97 [0.88-1.08],0.625144278396961,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.91 [0.62-1.33],0.625469859184753,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,1.04 [0.88-1.23],0.626607903732624,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.99 [0.93-1.05],0.627547561360746,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.11 [0.74-1.66],0.627825885306531,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.02 [0.94-1.11],0.627964018282055,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.03 [0.92-1.15],0.629802010753372,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MILR1,Allergin-1,Inverse variance weighted,33,1 [0.99-1.02],0.630373375452345,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM,Paralemmin-1,Inverse variance weighted,6,1.02 [0.94-1.11],0.631582932001817,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK8,Kallikrein-8,Inverse variance weighted,12,0.99 [0.94-1.04],0.63264418416109,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.93 [0.7-1.24],0.634461996604918,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP2,Neuropilin-2,Inverse variance weighted,11,0.98 [0.92-1.05],0.634705003920813,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.05 [0.85-1.31],0.63774991677973,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PVR,Poliovirus receptor,Inverse variance weighted,27,1.01 [0.98-1.03],0.639132943903679,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.09 [0.76-1.57],0.646321985472103,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.99 [0.96-1.03],0.64735632278326,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.94-1.1],0.652001039019776,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.01 [0.98-1.03],0.655670171563885,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1 [0.99-1.02],0.655716845718412,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANG,Angiogenin,Inverse variance weighted,19,1.01 [0.97-1.05],0.656426333588202,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYOM3,Myomesin-3,Wald ratio,1,0.95 [0.76-1.19],0.657924364580256,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.02 [0.93-1.12],0.658295243799565,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.97 [0.87-1.09],0.659258874237231,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.01 [0.95-1.08],0.660856377536903,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1.08 [0.77-1.51],0.663122254214338,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.99 [0.94-1.04],0.663236593752947,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.01 [0.95-1.09],0.664657419093192,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.99 [0.93-1.05],0.668818566595466,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPP1,Osteopontin,Inverse variance weighted,8,0.98 [0.87-1.1],0.670776251147727,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.92-1.14],0.671769800319628,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.01 [0.96-1.07],0.675546801397473,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.02 [0.94-1.1],0.679064587664175,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.01 [0.97-1.04],0.679562121788459,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.07 [0.76-1.51],0.682226301752831,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.96-1.03],0.68260821505077,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.98-1.04],0.683597150766434,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,1.07 [0.77-1.5],0.684718608664044,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.92 [0.62-1.37],0.686945768059988,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.99 [0.95-1.03],0.688322959645463,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNC,Tenascin,Inverse variance weighted,12,1.01 [0.94-1.09],0.68978994971411,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.92-1.13],0.690367972877145,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.99 [0.92-1.06],0.691000756823594,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.97-1.02],0.692687018044146,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMN,Protein amnionless,Inverse variance weighted,39,1 [0.98-1.03],0.693918464447926,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.01 [0.96-1.07],0.695519528356383,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HJV,Hemojuvelin,Wald ratio,1,0.98 [0.89-1.08],0.695752842646183,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.99 [0.96-1.03],0.696197617391059,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP1,Neuropilin-1,Inverse variance weighted,12,0.99 [0.95-1.04],0.697082919551523,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MME,Neprilysin,Inverse variance weighted,3,0.96 [0.78-1.18],0.698168731650347,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPIND1,Heparin cofactor 2,Wald ratio,1,0.96 [0.78-1.19],0.702878941216744,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CX3CL1,Fractalkine,Inverse variance weighted,9,0.98 [0.91-1.07],0.703176803833276,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.99 [0.94-1.05],0.706253462878488,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTA4H,Leukotriene A-4 hydrolase,Inverse variance weighted,2,1.04 [0.86-1.26],0.708835645851889,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.03 [0.88-1.21],0.710596018216476,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.02 [0.92-1.12],0.711243791602923,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,1.01 [0.95-1.09],0.712248841395072,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.01 [0.96-1.06],0.71343809804908,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.99 [0.94-1.04],0.713685424649009,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.98 [0.89-1.09],0.7173612058918,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.01 [0.96-1.07],0.719841341395614,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.02 [0.93-1.11],0.720946283886253,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.06 [0.77-1.45],0.723917283162286,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.03],0.729227830402664,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.02 [0.92-1.13],0.730000403277014,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,1.01 [0.97-1.04],0.739816298727858,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRTN3,Myeloblastin,Inverse variance weighted,21,0.99 [0.96-1.03],0.741969351210644,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18,Interleukin-18,Inverse variance weighted,16,1.02 [0.9-1.16],0.745743112941751,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MFGE8,Lactadherin,Inverse variance weighted,11,0.99 [0.92-1.06],0.746885026800084,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.98 [0.87-1.1],0.748310521277679,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGA4,Pepsin A-4,Inverse variance weighted,2,1.04 [0.83-1.3],0.748856399337203,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.03 [0.87-1.2],0.749610122158514,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.03 [0.86-1.24],0.753382877371655,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.05 [0.77-1.43],0.754294869824936,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.98 [0.86-1.12],0.754501640002318,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.99 [0.95-1.04],0.755127436745254,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1 [0.98-1.01],0.756250348782117,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.95 [0.69-1.31],0.758442225646719,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.02 [0.88-1.18],0.765944642632808,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUSB,Beta-glucuronidase,Inverse variance weighted,4,1.03 [0.85-1.24],0.766878794150908,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.97 [0.76-1.22],0.767034086190355,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.97-1.03],0.767880565877294,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.97 [0.81-1.17],0.770198680043126,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.96-1.03],0.775595874670345,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.97-1.03],0.778323172342747,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.96-1.03],0.778552620903842,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.99 [0.91-1.08],0.778785136050172,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.98 [0.88-1.1],0.779205789258041,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.98 [0.87-1.11],0.781346793204968,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.02 [0.9-1.16],0.781442559490724,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.01 [0.96-1.06],0.784267124318863,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1 [0.98-1.03],0.787660610426764,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.01 [0.96-1.06],0.788964839363159,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFI,Complement factor I,Inverse variance weighted,6,1.01 [0.94-1.09],0.789090295822483,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.01 [0.94-1.08],0.789565692506552,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD160,CD160 antigen,Inverse variance weighted,11,0.99 [0.95-1.04],0.791508509263435,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.99 [0.89-1.09],0.79836573549612,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1.01 [0.95-1.07],0.8011650065964,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.97-1.04],0.803547699004913,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.99 [0.94-1.05],0.807982646035173,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1 [0.96-1.04],0.810585523206492,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.01 [0.95-1.07],0.811114417798302,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.01 [0.94-1.08],0.811566496404543,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1 [0.98-1.03],0.812566686030168,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.99 [0.88-1.1],0.813382721680959,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.98 [0.82-1.17],0.81359472227843,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.97-1.02],0.816467157087401,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.97-1.03],0.820065891472289,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSS,Cathepsin S,Inverse variance weighted,23,1 [0.97-1.04],0.822138245613019,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.97-1.04],0.822655337438987,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.96-1.04],0.82277323793971,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1 [0.98-1.02],0.822962359904623,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTBDN,Retbindin,Inverse variance weighted,3,0.99 [0.9-1.09],0.824399329547974,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.01 [0.91-1.13],0.832786014212572,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.97-1.03],0.833370678382749,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.01 [0.89-1.15],0.834090745530491,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1 [0.97-1.02],0.834310659129427,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,0.98 [0.78-1.22],0.834689431717185,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.99 [0.93-1.06],0.840545943878957,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,0.98 [0.82-1.17],0.840782712339086,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.99 [0.86-1.13],0.845686360558791,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA2,Integrin alpha-2,Inverse variance weighted,31,1 [0.97-1.03],0.849295614563991,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.05 [0.65-1.68],0.853571260739561,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.01 [0.92-1.11],0.855826424281341,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.99 [0.92-1.08],0.856035616312491,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1 [0.97-1.03],0.858177396203149,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.01 [0.94-1.07],0.86057249499061,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DSC2,Desmocollin-2,Inverse variance weighted,9,0.99 [0.94-1.06],0.864150733501435,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK11,Kallikrein-11,Inverse variance weighted,6,1 [0.95-1.05],0.869101954024547,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAPK9,Mitogen-activated protein kinase 9,Inverse variance weighted,2,1.02 [0.77-1.36],0.870221857087979,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1 [0.98-1.03],0.87110824242978,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.03 [0.71-1.51],0.871216895955854,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.99 [0.86-1.14],0.871991206325302,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.99 [0.87-1.12],0.875416712993016,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH3,Cadherin-3,Inverse variance weighted,2,1.02 [0.83-1.24],0.877319575334233,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINH1,Serpin H1,Inverse variance weighted,3,1.01 [0.85-1.2],0.87939052472752,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100A12,Protein S100-A12,Inverse variance weighted,3,1.01 [0.94-1.08],0.880110516081273,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1 [0.96-1.05],0.882903145609071,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1 [0.93-1.07],0.893527928127495,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.98-1.02],0.893702394877999,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANXA10,Annexin A10,Wald ratio,1,0.98 [0.7-1.36],0.895809172950853,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.01 [0.85-1.21],0.896693958481526,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTN,Pleiotrophin,Inverse variance weighted,4,1.01 [0.84-1.22],0.898656139067108,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.02 [0.71-1.47],0.899684082860702,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.97-1.03],0.903912083729915,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.94-1.06],0.904002149727506,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.01 [0.83-1.24],0.904649911383639,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.02 [0.78-1.32],0.908461653649693,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.97 [0.54-1.73],0.90929718848266,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALCA,Calcitonin,Inverse variance weighted,5,1.01 [0.88-1.16],0.910713048390677,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.01 [0.9-1.13],0.911296135526935,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.01 [0.89-1.14],0.911661449353703,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD83,CD83 antigen,Inverse variance weighted,5,1 [0.92-1.1],0.913938568011185,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.87-1.14],0.915012778119175,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1 [0.97-1.04],0.915251160186232,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.99 [0.81-1.21],0.916498675135565,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.01 [0.9-1.12],0.916662804149878,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.88-1.12],0.916905239526346,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,0.99 [0.87-1.13],0.91750327954496,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1 [0.91-1.09],0.917797888437665,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.01 [0.9-1.12],0.919821049042685,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAXX,Protein PAXX,Inverse variance weighted,3,1.01 [0.91-1.11],0.919824829451564,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1 [0.94-1.07],0.921489268181555,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,1 [0.96-1.04],0.930065016933124,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.97-1.03],0.933057708784152,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1 [0.91-1.09],0.941035126469187,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.95-1.05],0.942524120578809,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC3B,Tetranectin,Inverse variance weighted,7,1 [0.93-1.07],0.943294770638763,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.93-1.08],0.945061771923421,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1 [0.94-1.07],0.94568899486605,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COLEC12,Collectin-12,Inverse variance weighted,11,1 [0.94-1.07],0.946742429459161,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,1 [0.94-1.06],0.947986723322403,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.96-1.04],0.948704683680886,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1 [0.89-1.11],0.953501086470356,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,1 [0.92-1.08],0.954796576981318,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STAB2,Stabilin-2,Inverse variance weighted,20,1 [0.97-1.03],0.955071857460652,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1 [0.94-1.07],0.956030595368582,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1 [0.91-1.09],0.95619798893551,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.97-1.03],0.957410858148225,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,1 [0.95-1.05],0.958001361425125,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1 [0.93-1.07],0.962470863751844,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PENK,Proenkephalin-A,Inverse variance weighted,19,1 [0.95-1.05],0.963146554670643,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRN,Progranulin,Inverse variance weighted,7,1 [0.95-1.06],0.965440901201893,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL19,Interleukin-19,Inverse variance weighted,11,1 [0.93-1.07],0.966841372168922,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1 [0.9-1.11],0.96759346563227,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.98-1.02],0.969852677386744,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1 [0.95-1.05],0.970432614687162,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1 [0.96-1.04],0.970524520396939,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPR,Nucleoprotein TPR,Wald ratio,1,1 [0.77-1.31],0.970956135578729,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1 [0.9-1.1],0.971105355990727,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1 [0.89-1.13],0.971483897709851,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1 [0.96-1.04],0.971515653021512,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1 [0.98-1.02],0.974132001651403,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.93-1.08],0.975168170491448,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRELP,Prolargin,Inverse variance weighted,9,1 [0.95-1.05],0.979449697625315,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.01 [0.51-1.98],0.980382473174615,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1 [0.83-1.2],0.982062597022801,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1 [0.88-1.14],0.982069052947811,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,1 [0.86-1.15],0.986860235094196,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1 [0.86-1.16],0.989028440979603,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1 [0.86-1.17],0.989221061441617,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1 [0.77-1.3],0.991409442642684,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STC1,Stanniocalcin-1,Inverse variance weighted,2,1 [0.78-1.29],0.992458867147747,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1 [0.88-1.13],0.992589572989834,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.98-1.02],0.994834048817967,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NFASC,Neurofascin,Inverse variance weighted,15,1 [0.95-1.05],0.997295760341255,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1 [0.91-1.09],0.999027321780998,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,3.78 [2.47-5.77],7.51067180619992e-10,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.8 [2.31-6.25],1.53978512082268e-07,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMNB1,Lamin-B1,Inverse variance weighted,3,1.41 [1.21-1.65],1.7455164392256e-05,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,2.09 [1.38-3.16],0.000488026371609125,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.11 [1.05-1.18],0.000521027560092648,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.6 [0.44-0.81],0.000703949574079983,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,0.8 [0.7-0.91],0.000974684753945631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINH1,Serpin H1,Inverse variance weighted,5,0.74 [0.61-0.89],0.00189264625303586,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.89 [0.83-0.96],0.00191893143184096,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.51 [1.16-1.97],0.00232885909698863,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.9 [0.84-0.96],0.00263960582017878,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.78 [0.66-0.92],0.00272536143844881,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.37 [1.11-1.69],0.00322212884824396,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.07 [1.02-1.12],0.00327647333958859,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.18 [1.05-1.32],0.00368962931795046,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.56 [1.15-2.11],0.00388286619105005,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.09 [1.03-1.16],0.00460053282425601,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.91 [0.85-0.97],0.0048679034892258,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.16 [1.05-1.28],0.0049066778051472,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSLN,Mesothelin,Inverse variance weighted,11,1.14 [1.04-1.25],0.00552773022047109,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FST,Follistatin,Wald ratio,1,1.63 [1.15-2.3],0.00622909216952157,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.55 [0.36-0.85],0.0063030065812733,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.82 [0.71-0.95],0.00799408745735484,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MME,Neprilysin,Inverse variance weighted,46,1.05 [1.01-1.09],0.0088772274378762,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.4 [1.09-1.8],0.00888849485913383,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK8,Kallikrein-8,Inverse variance weighted,5,0.81 [0.69-0.95],0.00929302312349652,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAN,Aggrecan core protein,Inverse variance weighted,30,1.08 [1.02-1.15],0.00947681944221499,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CST3,Cystatin-C,Inverse variance weighted,3,1.35 [1.07-1.7],0.0103623152419703,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.23 [1.05-1.45],0.0106857063061755,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.72 [0.57-0.93],0.0108930619375313,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.91 [0.84-0.98],0.0110579049271069,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.03 [1.01-1.05],0.0115330413756305,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.61 [0.41-0.9],0.0136506611588913,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.16 [1.03-1.31],0.0152022110181303,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.04 [1.01-1.07],0.0155727301337685,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.24 [1.04-1.48],0.0167457997605829,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.87 [0.78-0.98],0.0183011888606398,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,0.95 [0.92-0.99],0.021358592938828,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFD,Complement factor D,Wald ratio,1,0.66 [0.46-0.94],0.0221951832600391,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.46 [1.05-2.03],0.0229339049509814,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.07 [1.01-1.13],0.0229695763924549,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.87 [0.78-0.98],0.0269150438842471,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.89 [0.8-0.99],0.0315880213734146,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.13 [1.01-1.25],0.0343188437471468,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.74 [0.55-0.98],0.0363915545000525,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.17 [1.01-1.35],0.0376248188809602,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.19 [1.01-1.4],0.0386175063639784,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGMN,Legumain,Inverse variance weighted,22,1.1 [1-1.21],0.0394731456348734,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.05 [1-1.1],0.0426684859476908,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,F9,Coagulation factor IX,Inverse variance weighted,3,1.28 [1.01-1.62],0.0431996977418445,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,0.81 [0.66-0.99],0.0433288803013012,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.19 [1-1.42],0.0440811195377422,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.15 [1-1.31],0.0446075857008697,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.05 [1-1.1],0.0454821863271201,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.86 [0.74-1],0.0465421963932929,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.44 [1.01-2.06],0.0468062270733203,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BSG,Basigin,Inverse variance weighted,6,0.86 [0.74-1],0.0475994170587307,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WNT9A,Protein Wnt-9a,Wald ratio,1,0.62 [0.38-1],0.0478711305768876,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.87 [0.76-1],0.049046527687578,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MPO,Myeloperoxidase,Inverse variance weighted,17,0.94 [0.89-1],0.0516311981814126,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KYNU,Kynureninase,Inverse variance weighted,3,1.71 [1-2.95],0.0520481261396212,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.22 [1-1.49],0.0529252797145925,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,1.21 [1-1.47],0.0531198938174419,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MDK,Midkine,Inverse variance weighted,14,1.15 [1-1.32],0.053688369183857,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO1,R-spondin-1,Inverse variance weighted,8,0.89 [0.78-1],0.0541871660525797,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.95 [0.9-1],0.0557409315107275,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.43 [0.99-2.05],0.0567429947903017,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGA,Chromogranin-A,Inverse variance weighted,5,1.13 [1-1.28],0.0594429404210718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.9 [0.8-1.01],0.0624815159950277,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,1.05 [1-1.11],0.0625162612174637,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,1.12 [0.99-1.25],0.063174360522067,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.11 [0.99-1.24],0.0658753741527561,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAN,Versican core protein,Inverse variance weighted,30,0.95 [0.9-1],0.0663567619979153,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C7,Complement component C7,Inverse variance weighted,26,1.03 [1-1.07],0.0670382184273631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.76 [0.57-1.02],0.0690147237649584,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CELA2A,Chymotrypsin-like elastase family member 2A,Inverse variance weighted,31,0.95 [0.9-1],0.0699836921413581,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS9,Galectin-9,Inverse variance weighted,36,1.03 [1-1.07],0.0708231144057368,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.72 [0.51-1.03],0.07362447012001,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.94 [0.88-1.01],0.075290600502261,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.99-1.13],0.0758751592166763,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.82 [0.66-1.02],0.0767437274497574,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.9-1.01],0.0791592573410336,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.86 [0.73-1.02],0.0805355631004849,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.96 [0.91-1.01],0.0822132215408088,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.92 [0.84-1.01],0.0825618625861238,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.1 [0.99-1.23],0.0836404855747574,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.89 [0.78-1.02],0.0839825132446116,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.03 [1-1.06],0.0867742251136799,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.99-1.1],0.0870189885081631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.16 [0.98-1.37],0.0877327961878636,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.93 [0.85-1.01],0.088724633695135,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.25 [0.96-1.62],0.0923759607892212,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.23 [0.97-1.56],0.0939810232074852,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.97 [0.94-1.01],0.0950377269644051,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,15,0.86 [0.72-1.03],0.0984528127007944,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.24 [0.96-1.61],0.0997154729932261,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.87 [0.73-1.03],0.10144438314713,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PI3,Elafin,Inverse variance weighted,18,1.05 [0.99-1.11],0.102779847071102,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.16 [0.97-1.39],0.103515390801781,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,1.1 [0.98-1.23],0.104131261482171,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.88 [0.75-1.03],0.104214322723334,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.15 [0.97-1.35],0.104256240994423,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.93 [0.86-1.01],0.105090523026316,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.71 [0.46-1.08],0.105102639810517,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.86 [0.71-1.03],0.106478678076114,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.15 [0.97-1.36],0.109670848365087,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.08 [0.98-1.18],0.109756602290855,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.04 [0.99-1.1],0.111050957957392,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.18 [0.96-1.46],0.113184237590318,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.19 [0.96-1.47],0.114450574349237,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,0.89 [0.76-1.03],0.114598509214041,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCN1,Ficolin-1,Inverse variance weighted,50,0.97 [0.94-1.01],0.114679098265985,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.95 [0.9-1.01],0.117792496910311,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POF1B,Protein POF1B,Inverse variance weighted,4,0.89 [0.76-1.03],0.119544686988847,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.85 [0.7-1.04],0.119777419810125,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1.03 [0.99-1.06],0.120537843120983,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.94 [0.86-1.02],0.12187094197643,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMBP,Protein AMBP,Inverse variance weighted,5,1.08 [0.98-1.2],0.125629906456944,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP1,Interstitial collagenase,Inverse variance weighted,15,0.94 [0.88-1.02],0.126577491276332,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.07 [0.98-1.16],0.132354262284766,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.97 [0.93-1.01],0.133926782935837,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.04 [0.99-1.1],0.134021402754535,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.06 [0.98-1.13],0.134736848868853,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRTN3,Myeloblastin,Inverse variance weighted,20,1.08 [0.98-1.19],0.135975858699524,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.96 [0.91-1.01],0.137536567318562,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.05 [0.98-1.12],0.140574790280794,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.08 [0.98-1.19],0.141874177050174,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.89-1.02],0.142907589305284,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.91 [0.81-1.03],0.143418255194749,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,1.08 [0.97-1.2],0.148048373536156,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.87 [0.73-1.05],0.148981858148392,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COMP,Cartilage oligomeric matrix protein,Inverse variance weighted,9,1.1 [0.97-1.25],0.149684027239359,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.04 [0.99-1.09],0.151638571688005,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.23 [0.93-1.62],0.153406929311003,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.9 [0.79-1.04],0.153712435612066,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,1.15 [0.95-1.38],0.159027283848445,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.9 [0.78-1.04],0.159697132913136,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.28 [0.9-1.83],0.162889794416372,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.14 [0.95-1.37],0.164570478761459,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.8 [0.58-1.1],0.166443517135083,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.1 [0.96-1.26],0.168566193388395,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL19,Interleukin-19,Inverse variance weighted,10,1.05 [0.98-1.12],0.170193616664646,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.79 [0.57-1.11],0.172080666381853,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.14 [0.94-1.39],0.173928071076707,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.93 [0.84-1.03],0.175851497815515,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.03 [0.99-1.07],0.176158971724821,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.96-1.01],0.177499744062726,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.92 [0.82-1.04],0.180793316415297,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.02 [0.99-1.05],0.180833627251378,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM2,Paralemmin-2,Inverse variance weighted,9,1.05 [0.98-1.13],0.18383701424685,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.33 [0.87-2.04],0.188686687551904,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.07 [0.97-1.17],0.189475196461054,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.92 [0.82-1.04],0.189519413956718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.08 [0.96-1.21],0.191541102525747,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGRN,Agrin,Inverse variance weighted,14,0.94 [0.86-1.03],0.192510506481134,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.33 [0.87-2.04],0.192814248915391,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,4,1.14 [0.94-1.39],0.193311953401112,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,3,0.91 [0.78-1.05],0.195524769655075,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.11 [0.95-1.31],0.198339395422403,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.1 [0.95-1.27],0.19977636394831,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.15 [0.93-1.42],0.199857583868087,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PYY,Peptide YY,Inverse variance weighted,16,1.04 [0.98-1.09],0.199929457610533,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.9-1.02],0.20049009351484,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.03 [0.99-1.07],0.203742296046933,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.15 [0.92-1.44],0.205172010509071,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP2,Neuropilin-2,Inverse variance weighted,14,1.09 [0.95-1.24],0.207338348636919,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,1.1 [0.95-1.27],0.208305653702631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNC,Tenascin,Inverse variance weighted,57,1.02 [0.99-1.06],0.215137035909457,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.11 [0.94-1.29],0.216147211180289,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.12 [0.94-1.34],0.21884270567161,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.99-1.04],0.222192769306993,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.11 [0.94-1.33],0.222477779950686,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.06 [0.96-1.18],0.226631723224756,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.88 [0.71-1.08],0.226736140895959,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.08 [0.95-1.22],0.228347111876731,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.08 [0.95-1.22],0.230176463115628,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PXN,Paxillin,Inverse variance weighted,7,1.11 [0.94-1.32],0.230478441511265,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.93 [0.81-1.05],0.23591591909275,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.97 [0.93-1.02],0.238125784414725,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.14 [0.91-1.43],0.238154018865888,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.11 [0.93-1.32],0.238295310715389,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.08 [0.95-1.22],0.238917218697015,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.32 [0.83-2.11],0.239397589272683,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.08 [0.95-1.23],0.242583723938356,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.09 [0.95-1.25],0.24371869765758,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.17 [0.9-1.54],0.245528554127729,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.96 [0.9-1.03],0.245868916691936,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COLEC12,Collectin-12,Inverse variance weighted,3,1.29 [0.84-1.99],0.246477061793943,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HJV,Hemojuvelin,Inverse variance weighted,2,0.84 [0.63-1.13],0.247263291784742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.05 [0.96-1.15],0.248859246582992,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,0.86 [0.67-1.11],0.250085570111717,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.95 [0.88-1.04],0.25280046702449,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.87 [0.69-1.1],0.253007381864582,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.97 [0.92-1.02],0.254771970726675,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.93 [0.81-1.06],0.255188333854234,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.97 [0.92-1.02],0.255585395731678,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYOM3,Myomesin-3,Inverse variance weighted,24,0.96 [0.89-1.03],0.257117063039966,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.02 [0.99-1.05],0.257391318011093,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP13,Collagenase 3,Wald ratio,1,1.24 [0.86-1.79],0.258076145742988,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.02 [0.99-1.04],0.258504519167919,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP7,Matrilysin,Wald ratio,1,0.91 [0.78-1.07],0.261202174484932,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.91 [0.77-1.07],0.261629218656444,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.96 [0.9-1.03],0.26203890013922,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.18 [0.88-1.6],0.269537474288966,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA2,Integrin alpha-2,Inverse variance weighted,13,0.94 [0.85-1.05],0.269731432647932,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.04 [0.97-1.11],0.270733882925911,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,6,0.93 [0.82-1.06],0.274740459789732,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH3,Cadherin-3,Inverse variance weighted,10,1.13 [0.91-1.41],0.276203620280884,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.88 [0.7-1.11],0.2779479307383,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RETN,Resistin,Inverse variance weighted,19,1.07 [0.95-1.2],0.279352368452881,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.93 [0.81-1.06],0.280277194873486,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL14,C-X-C motif chemokine 14,Inverse variance weighted,4,0.91 [0.78-1.08],0.282504806992309,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.77 [0.49-1.23],0.282508577278755,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.03 [0.97-1.1],0.284379094115032,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.96 [0.89-1.03],0.284760052308649,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.03 [0.98-1.07],0.2857076537768,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.22 [0.84-1.77],0.285981025823488,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUCA2A,Guanylin,Inverse variance weighted,7,1.09 [0.93-1.27],0.288457171724076,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.98 [0.95-1.02],0.290901952152003,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IDS,Iduronate 2-sulfatase,Inverse variance weighted,3,1.05 [0.96-1.14],0.291354253864972,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.02 [0.98-1.06],0.292050721007864,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.1 [0.92-1.3],0.296508808492985,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BRK1,Protein BRICK1,Inverse variance weighted,10,0.94 [0.84-1.06],0.298345514471521,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.03 [0.97-1.1],0.299189364589904,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.07 [0.94-1.21],0.299497977798367,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.16 [0.88-1.54],0.300748903291084,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.21 [0.84-1.76],0.301658073209208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.03 [0.97-1.1],0.30417914716586,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYL3,Myosin light chain 3,Inverse variance weighted,14,0.95 [0.87-1.05],0.306894684761208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.03 [0.97-1.09],0.306952595850653,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.04 [0.96-1.14],0.309553879279147,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,40,1.02 [0.98-1.06],0.315752592481931,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAYN,Layilin,Inverse variance weighted,3,1.3 [0.78-2.17],0.319782248736532,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWC2,Brorin,Inverse variance weighted,12,1.08 [0.93-1.25],0.320396519954273,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.96 [0.89-1.04],0.32063994734572,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.21 [0.83-1.79],0.322686409683994,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,0.87 [0.66-1.15],0.323245992551827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.1 [0.91-1.33],0.325855573102851,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.04 [0.96-1.12],0.327873434066284,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPO,Erythropoietin,Inverse variance weighted,11,1.03 [0.97-1.1],0.329380762848684,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.09 [0.91-1.31],0.330346327291605,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.12 [0.89-1.42],0.332181652853937,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.89 [0.7-1.13],0.336548451449687,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.02 [0.98-1.05],0.337136890972221,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK4,Kallikrein-4,Inverse variance weighted,5,0.9 [0.73-1.11],0.33797865013997,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KITLG,Kit ligand,Inverse variance weighted,30,0.97 [0.92-1.03],0.33841456704247,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.09 [0.91-1.32],0.340447754421517,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.94 [0.83-1.07],0.344945478566201,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.97 [0.92-1.03],0.346466020421875,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN2,Nectin-2,Inverse variance weighted,3,1.16 [0.85-1.6],0.347863685618474,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,0.91 [0.75-1.11],0.352603913983963,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.91 [0.76-1.1],0.354347540400627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.06 [0.94-1.19],0.355629662086627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.88 [0.66-1.16],0.360646480272187,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCG,Pro-glucagon,Inverse variance weighted,2,1.13 [0.87-1.46],0.361162985812702,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADIPOQ,Adiponectin,Inverse variance weighted,25,1.03 [0.97-1.1],0.36214409094788,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.9 [0.72-1.13],0.363049770919581,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS3,Galectin-3,Inverse variance weighted,15,0.96 [0.88-1.05],0.364826083433466,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,6,0.94 [0.82-1.08],0.365068656176146,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN4,Nectin-4,Inverse variance weighted,4,1.16 [0.84-1.61],0.365430718131305,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.06 [0.94-1.19],0.365936319944996,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.95 [0.85-1.06],0.366281893843757,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,1.01 [0.99-1.03],0.368625617534118,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.95 [0.86-1.06],0.369946904588278,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.88 [0.66-1.17],0.371220601499053,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MANSC4,MANSC domain-containing protein 4,Inverse variance weighted,7,0.92 [0.78-1.1],0.371907889543914,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1.05 [0.94-1.16],0.372112702445334,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CAPG,Macrophage-capping protein,Wald ratio,1,1.15 [0.84-1.58],0.372986332277028,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.02 [0.97-1.08],0.373937964292624,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSL,Cathepsin L1,Inverse variance weighted,29,1.03 [0.97-1.1],0.379221852282012,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRH,Corticoliberin,Inverse variance weighted,55,1.02 [0.98-1.05],0.379541642180009,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.05 [0.94-1.18],0.382392653456784,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.82 [0.53-1.27],0.382758830070334,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,0.95 [0.86-1.06],0.382774049022537,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MILR1,Allergin-1,Inverse variance weighted,43,1.01 [0.99-1.03],0.386659597168023,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,0.87 [0.63-1.19],0.387483020472214,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.13 [0.86-1.5],0.388286941876104,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.04 [0.95-1.14],0.388521210299381,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.05 [0.94-1.17],0.388703502339987,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.97-1.01],0.397439553307317,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.94 [0.82-1.08],0.398655271862639,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.17 [0.82-1.66],0.399463972730307,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CBLN4,Cerebellin-4,Inverse variance weighted,17,0.98 [0.92-1.03],0.404908061643976,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.04 [0.95-1.13],0.40507417311425,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN1,Contactin-1,Inverse variance weighted,25,1.03 [0.96-1.11],0.405201830592354,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.84 [0.55-1.28],0.406850718677155,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAN,Brevican core protein,Inverse variance weighted,12,0.96 [0.86-1.07],0.410782029201415,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XG,Glycoprotein Xg,Inverse variance weighted,2,1.13 [0.85-1.5],0.41092708513247,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALB1,Calbindin,Inverse variance weighted,9,0.96 [0.87-1.06],0.41331665394564,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.25 [0.73-2.12],0.414741661075536,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.09 [0.88-1.35],0.414782594292714,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.03 [0.96-1.09],0.415710439319896,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.09 [0.88-1.34],0.416592691743786,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS4,Galectin-4,Inverse variance weighted,15,0.98 [0.94-1.03],0.417608131968343,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,1.06 [0.92-1.24],0.417771478090281,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.07 [0.91-1.26],0.419859756504448,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STAB2,Stabilin-2,Inverse variance weighted,14,1.05 [0.94-1.17],0.41996339696251,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.28 [0.7-2.34],0.422093913782354,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.94 [0.81-1.09],0.424568636879217,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD302,CD302 antigen,Inverse variance weighted,11,0.97 [0.89-1.05],0.428572806293609,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL6,Interleukin-6,Inverse variance weighted,6,0.96 [0.85-1.07],0.431545390431693,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.05 [0.93-1.18],0.434857805021817,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OCLN,Occludin,Inverse variance weighted,2,0.91 [0.72-1.15],0.436518943020172,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.98 [0.93-1.03],0.438168883147058,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.92 [0.74-1.14],0.439919481040843,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,1.19 [0.77-1.85],0.440241984848281,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSD,Cathepsin D,Inverse variance weighted,7,1.06 [0.91-1.25],0.442199460151419,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.03 [0.96-1.1],0.442978979303709,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.9 [0.7-1.17],0.443049710702057,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.95 [0.85-1.08],0.445444425778026,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.98-1.04],0.4456096436742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.03 [0.96-1.09],0.445681725462222,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.02 [0.97-1.06],0.446627797078035,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH1,Cadherin-1,Inverse variance weighted,16,0.97 [0.9-1.05],0.446849443887781,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTN,Pleiotrophin,Inverse variance weighted,3,1.07 [0.89-1.29],0.447948506130083,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN2,Contactin-2,Inverse variance weighted,11,1.1 [0.86-1.41],0.448906461248486,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.95 [0.84-1.08],0.45024021443867,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DRAXIN,Draxin,Inverse variance weighted,25,1.03 [0.95-1.11],0.450467676742713,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK11,Kallikrein-11,Inverse variance weighted,13,1.03 [0.95-1.13],0.450751240190349,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,23,0.97 [0.88-1.06],0.451642090813378,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.12 [0.83-1.52],0.452219738408342,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.1 [0.86-1.42],0.45302060457595,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.96 [0.88-1.06],0.457153736489815,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.94 [0.81-1.1],0.458225220510501,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.92 [0.73-1.15],0.458877518222394,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGB,Secretogranin-1,Inverse variance weighted,7,0.95 [0.82-1.1],0.458959651435302,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.06 [0.91-1.24],0.462713050226926,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GHRL,Appetite-regulating hormone,Inverse variance weighted,14,0.96 [0.86-1.07],0.462880801701653,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.04 [0.94-1.15],0.463369085140135,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.94 [0.79-1.11],0.463995454545284,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.02 [0.97-1.06],0.465294254470561,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.08 [0.88-1.34],0.465482433837503,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.05 [0.92-1.21],0.46687402975235,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMNB2,Lamin-B2,Inverse variance weighted,8,1.05 [0.92-1.19],0.468418649528516,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.8 [0.44-1.47],0.469455767237627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.97 [0.9-1.05],0.472319278505119,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD83,CD83 antigen,Inverse variance weighted,14,0.96 [0.85-1.08],0.473318962881371,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.96 [0.84-1.08],0.473403984802458,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC1,Syndecan-1,Inverse variance weighted,12,0.96 [0.86-1.08],0.473701484671453,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.95-1.02],0.479764413649822,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.02 [0.97-1.07],0.480293130394291,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.87 [0.6-1.28],0.482492838093721,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.09 [0.86-1.38],0.485466837426019,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NGRN,Neugrin,Inverse variance weighted,4,1.06 [0.9-1.24],0.486864085445017,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD27,CD27 antigen,Inverse variance weighted,9,1.11 [0.82-1.5],0.487715151523991,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.07 [0.89-1.28],0.490359656338835,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUSB,Beta-glucuronidase,Inverse variance weighted,31,0.97 [0.9-1.05],0.491726735970291,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,31,0.97 [0.89-1.06],0.492370728637163,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEPTIN8,Septin-8,Inverse variance weighted,4,0.95 [0.81-1.11],0.493687008724797,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.97 [0.9-1.05],0.493812134974605,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCAN,Neurocan core protein,Inverse variance weighted,19,0.97 [0.89-1.06],0.500413975296815,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.94 [0.78-1.13],0.501022139250302,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.97 [0.89-1.06],0.501259890925284,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1.1 [0.83-1.44],0.502927818162371,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.06 [0.9-1.25],0.50313111243455,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.95 [0.83-1.1],0.513269877335617,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.97 [0.9-1.05],0.513743186289847,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.1 [0.82-1.48],0.514242970418228,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.93 [0.74-1.17],0.51576416729873,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPL,Periplakin,Inverse variance weighted,2,0.83 [0.48-1.45],0.517088033286752,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.05 [0.91-1.22],0.517966602965078,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MVK,Mevalonate kinase,Wald ratio,1,1.32 [0.57-3.09],0.518854187869087,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.15 [0.75-1.76],0.522145373995458,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.91 [0.69-1.21],0.522196796929717,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.04 [0.92-1.18],0.522222257920838,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINB8,Serpin B8,Inverse variance weighted,29,0.99 [0.97-1.02],0.522304672740738,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.95 [0.81-1.12],0.523082996428254,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRND,Prion-like protein doppel,Inverse variance weighted,15,1.04 [0.93-1.16],0.523411167966341,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFC1,Cryptic protein,Inverse variance weighted,11,0.96 [0.86-1.08],0.524177428740421,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.91-1.05],0.526802004108661,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.92 [0.71-1.19],0.526911432744894,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.97 [0.88-1.07],0.530396888506409,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.02 [0.95-1.1],0.531789059681201,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,0.96 [0.86-1.08],0.532545187828422,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1.01 [0.97-1.06],0.539367300482824,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGES2,Prostaglandin E synthase 2,Inverse variance weighted,2,1.07 [0.86-1.35],0.541050052764239,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.99 [0.96-1.02],0.541619621949256,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.97 [0.88-1.07],0.541695605062426,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.97 [0.89-1.06],0.544973225888781,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCTN3,Tectonic-3,Inverse variance weighted,44,1.01 [0.98-1.04],0.548174086032927,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.94 [0.78-1.14],0.550942551883776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.98 [0.92-1.05],0.55124603605591,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,0.95 [0.81-1.12],0.551541315818833,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAP2,Microtubule-associated protein 2,Inverse variance weighted,8,1.1 [0.8-1.53],0.552575680596827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.07 [0.85-1.35],0.552802225570203,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.03 [0.94-1.12],0.55597991591306,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.92 [0.71-1.2],0.556753043770148,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.04 [0.92-1.17],0.5580811417374,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.98 [0.9-1.06],0.558996639159791,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.29 [0.54-3.08],0.560719901499835,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.14 [0.73-1.78],0.562740712783922,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.98 [0.9-1.06],0.568469233695718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.85 [0.5-1.47],0.568926308761792,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.95 [0.8-1.13],0.571199368296968,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.98 [0.91-1.05],0.571657505387722,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.96 [0.83-1.11],0.571749166772933,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.98 [0.91-1.05],0.572258724177183,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.95 [0.8-1.13],0.573457421293647,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UMOD,Uromodulin,Inverse variance weighted,34,0.98 [0.9-1.06],0.573953557051903,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.97 [0.88-1.07],0.574583328297306,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MUC13,Mucin-13,Inverse variance weighted,3,0.94 [0.74-1.18],0.576094362646312,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.97 [0.86-1.09],0.577750087291462,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.93 [0.72-1.2],0.578149703165667,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.99 [0.96-1.02],0.582162092452362,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.04 [0.91-1.18],0.586290456986103,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.98 [0.93-1.04],0.587098613158341,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCOF1,Treacle protein,Wald ratio,1,1.12 [0.75-1.66],0.589676639930514,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.98 [0.91-1.05],0.589930561952347,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.94 [0.75-1.18],0.591583457762855,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.96 [0.84-1.1],0.595150845871824,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFI,Complement factor I,Wald ratio,1,0.87 [0.52-1.45],0.595696857728134,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.04 [0.91-1.18],0.596409949324641,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,1.01 [0.98-1.04],0.596540691270236,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.97-1.06],0.596826650992547,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.97 [0.88-1.08],0.598123745393838,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.03 [0.93-1.14],0.599386908187631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,0.97 [0.86-1.09],0.600545580464595,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.91 [0.63-1.31],0.601120666213979,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.97 [0.85-1.1],0.601169084601528,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.96 [0.8-1.14],0.608874490806765,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FBLN2,Fibulin-2,Inverse variance weighted,6,0.94 [0.75-1.18],0.610478501399712,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.04 [0.9-1.2],0.614206271390873,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.98 [0.91-1.06],0.614478655126335,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMN,Protein amnionless,Inverse variance weighted,3,1.05 [0.87-1.27],0.61589440017271,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.97 [0.87-1.09],0.616565506326289,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.01 [0.97-1.04],0.616704299439225,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.96 [0.84-1.11],0.624092719061917,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.03 [0.92-1.15],0.625590989324604,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FETUB,Fetuin-B,Inverse variance weighted,5,0.93 [0.71-1.23],0.626049454138106,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.97 [0.84-1.11],0.62663611150259,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.96 [0.82-1.13],0.627470188821112,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100P,Protein S100-P,Inverse variance weighted,4,0.96 [0.8-1.14],0.628306943143996,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.98 [0.89-1.07],0.628441706626231,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.04 [0.89-1.21],0.62979913760627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.03 [0.93-1.14],0.630035144827776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.96 [0.82-1.13],0.63028425274185,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPP1,Osteopontin,Inverse variance weighted,13,0.97 [0.84-1.11],0.635063706812208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,0.99 [0.96-1.02],0.635312975343664,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.95 [0.77-1.17],0.635369566477592,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.95 [0.75-1.19],0.635984017487851,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.98-1.04],0.636142787717152,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.01 [0.96-1.07],0.640065185909912,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GLA,Alpha-galactosidase A,Inverse variance weighted,2,1.05 [0.86-1.29],0.641758731524833,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.04 [0.89-1.22],0.645990528463902,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.94 [0.72-1.23],0.646577660741686,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DNM3,Dynamin-3,Inverse variance weighted,11,1.02 [0.95-1.09],0.646673410773587,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,0.97 [0.86-1.1],0.647288119017901,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,0.97 [0.86-1.1],0.647494131140611,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSS,Cathepsin S,Inverse variance weighted,7,1.03 [0.91-1.17],0.650207303124777,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.96 [0.81-1.14],0.651302990906036,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,1.03 [0.9-1.19],0.652790912572111,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALCA,Calcitonin,Inverse variance weighted,13,0.97 [0.87-1.09],0.65546744961097,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.02 [0.93-1.13],0.65757001021362,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCN,Decorin,Inverse variance weighted,2,0.79 [0.28-2.24],0.659116115032102,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100A12,Protein S100-A12,Inverse variance weighted,4,1.06 [0.82-1.38],0.660366538437623,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN2,Matrilin-2,Inverse variance weighted,28,1.01 [0.97-1.04],0.662763137422683,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.97 [0.83-1.12],0.663542428757908,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PVR,Poliovirus receptor,Inverse variance weighted,3,1.14 [0.63-2.06],0.663907715474982,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,4,0.96 [0.8-1.16],0.66520015834235,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.99 [0.95-1.03],0.665821512197112,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.04 [0.88-1.22],0.669072257070973,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1.03 [0.9-1.17],0.669313661546574,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTBDN,Retbindin,Inverse variance weighted,2,0.93 [0.66-1.31],0.673199500130543,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.11 [0.68-1.83],0.674787122952822,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.04 [0.87-1.24],0.675003279885384,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSTB,Cystatin-B,Inverse variance weighted,23,0.99 [0.96-1.03],0.676971968860861,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.01 [0.97-1.05],0.679101957683328,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.01 [0.96-1.06],0.681413932970373,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.97-1.05],0.686289152775779,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.97 [0.86-1.1],0.686336929445742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.02 [0.93-1.11],0.687578673645718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.06 [0.79-1.43],0.689539096183954,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.02 [0.94-1.1],0.68956780527735,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD160,CD160 antigen,Inverse variance weighted,24,1.02 [0.94-1.1],0.690126579316722,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.98 [0.88-1.09],0.692644968689499,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.98 [0.89-1.08],0.693925944582594,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1 [0.98-1.03],0.694880526428834,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,0.96 [0.76-1.2],0.695779997929201,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.99 [0.92-1.05],0.698543273268162,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PENK,Proenkephalin-A,Inverse variance weighted,15,0.99 [0.92-1.06],0.700688541569149,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.97 [0.84-1.13],0.700940847584547,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD99,CD99 antigen,Inverse variance weighted,4,0.97 [0.81-1.15],0.701449624036711,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON1,Spondin-1,Inverse variance weighted,4,0.97 [0.81-1.15],0.704292880573286,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANG,Angiogenin,Inverse variance weighted,8,1.04 [0.86-1.25],0.704399062685062,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.01 [0.94-1.1],0.706295107326811,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS8,Prostasin,Inverse variance weighted,14,1.02 [0.93-1.11],0.708315870919393,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGF,Placenta growth factor,Inverse variance weighted,5,0.97 [0.82-1.14],0.710671937991164,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPT,Dermatopontin,Inverse variance weighted,4,1.04 [0.85-1.28],0.710776282129257,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.98 [0.88-1.1],0.711645935118174,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.01 [0.95-1.08],0.712665199523624,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,0.89 [0.49-1.62],0.713930457072397,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.05 [0.81-1.36],0.714628305727161,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.98 [0.86-1.1],0.714998523602171,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD48,CD48 antigen,Inverse variance weighted,14,1.03 [0.89-1.19],0.717023356942245,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.03 [0.88-1.21],0.717789485736342,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,1.02 [0.94-1.1],0.718098710440903,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.94 [0.66-1.33],0.71838573534456,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.04 [0.83-1.32],0.718388981079819,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1.01 [0.97-1.05],0.718838650850764,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.99 [0.92-1.06],0.72269186819536,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN4,CCN family member 4,Inverse variance weighted,29,1.01 [0.97-1.04],0.723012587516712,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.02 [0.93-1.11],0.727232622075973,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCT,Secretin,Inverse variance weighted,5,0.97 [0.82-1.14],0.728381240440992,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.05 [0.79-1.41],0.72895774624087,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GAST,Gastrin,Inverse variance weighted,9,1.02 [0.93-1.12],0.732329329021429,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.95 [0.72-1.26],0.732697581039156,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18,Interleukin-18,Inverse variance weighted,26,1.01 [0.95-1.07],0.734511269953575,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.01 [0.94-1.09],0.738327295276951,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.04 [0.82-1.33],0.73900532751639,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.03 [0.88-1.19],0.742379552789592,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ELN,Elastin,Inverse variance weighted,10,1.02 [0.91-1.14],0.743609098565635,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Inverse variance weighted,2,1.08 [0.67-1.74],0.74535413602783,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.06 [0.74-1.52],0.745549224244887,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MFGE8,Lactadherin,Inverse variance weighted,15,0.98 [0.89-1.09],0.751547231774986,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.94 [0.62-1.41],0.751913772771636,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NFASC,Neurofascin,Inverse variance weighted,6,1.05 [0.76-1.47],0.752851245672665,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN5,CCN family member 5,Inverse variance weighted,12,1.01 [0.95-1.07],0.753061649868381,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.01 [0.97-1.05],0.755622299328352,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1 [0.97-1.03],0.758719518728488,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.03 [0.86-1.23],0.76073770115863,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.97 [0.79-1.19],0.762684102134673,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10,Interleukin-10,Inverse variance weighted,4,0.98 [0.87-1.11],0.763821971658204,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG2,Secretogranin-2,Inverse variance weighted,2,0.96 [0.76-1.22],0.765352933956935,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.02 [0.88-1.19],0.767360053878164,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.97-1.04],0.768576932645787,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM,Paralemmin-1,Inverse variance weighted,4,0.97 [0.79-1.19],0.770484383976225,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.98 [0.88-1.1],0.774018398824379,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.05 [0.75-1.47],0.775074404940456,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.99 [0.9-1.08],0.77580913662596,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,5,0.98 [0.84-1.14],0.776542606074029,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR15L,Protein GPR15L,Inverse variance weighted,13,1.01 [0.96-1.06],0.776562618632754,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.03 [0.85-1.23],0.777020744177417,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.1 [0.54-2.24],0.783989859016809,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.99 [0.91-1.07],0.784832010657735,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.03 [0.83-1.28],0.785064728903131,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.99 [0.91-1.08],0.785362490832195,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.95 [0.64-1.4],0.787017907750084,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.96 [0.74-1.25],0.787938149791755,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.04 [0.79-1.35],0.789250231753066,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,0.96 [0.74-1.26],0.790728441653237,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,2,1.05 [0.73-1.5],0.791309048800718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.06 [0.69-1.61],0.79537937204146,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.01 [0.93-1.09],0.795702850927349,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.02 [0.9-1.14],0.795884560594731,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,0.98 [0.86-1.12],0.7988092092364,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.97 [0.77-1.23],0.800147974203051,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,1.01 [0.94-1.08],0.80017478283674,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP1,Neuropilin-1,Inverse variance weighted,14,1.01 [0.91-1.14],0.807522281698778,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.98 [0.83-1.15],0.80966225912156,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CX3CL1,Fractalkine,Inverse variance weighted,12,0.98 [0.86-1.12],0.810852009658676,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.01 [0.96-1.06],0.813766997517271,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.01 [0.96-1.05],0.81400767025314,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.02 [0.87-1.19],0.818161037455155,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1 [0.96-1.04],0.818419435687351,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.99 [0.92-1.07],0.81863727864673,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.03 [0.78-1.36],0.819119718991041,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.02 [0.88-1.18],0.821587267881683,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.98 [0.8-1.2],0.824474964959275,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.97 [0.76-1.25],0.826278111217848,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH2,Cadherin-2,Inverse variance weighted,21,1.01 [0.93-1.09],0.827094569332554,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLGN,Calmegin,Inverse variance weighted,6,1.01 [0.92-1.11],0.827500923379553,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.02 [0.84-1.24],0.830188446454816,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SELENOP,Selenoprotein P,Inverse variance weighted,3,0.97 [0.76-1.25],0.832502803971301,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN5,Contactin-5,Inverse variance weighted,22,0.99 [0.94-1.05],0.833373978521416,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.03 [0.79-1.35],0.834563430298364,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.04 [0.73-1.47],0.835843733267449,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.99 [0.89-1.1],0.836530455816645,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.99 [0.9-1.09],0.83680859475122,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.97 [0.7-1.33],0.838782283317229,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.01 [0.92-1.1],0.840081842512124,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.04 [0.71-1.51],0.843281422438008,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.99 [0.94-1.05],0.844605904417169,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.03 [0.78-1.36],0.844659972565257,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.98 [0.83-1.17],0.845010272053532,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MB,Myoglobin,Inverse variance weighted,9,0.99 [0.88-1.11],0.846421393341349,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.02 [0.85-1.22],0.847206651424225,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.91-1.08],0.847551679395747,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.96-1.04],0.849183165480775,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.99 [0.88-1.12],0.850035043749208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POMC,Pro-opiomelanocortin,Inverse variance weighted,15,1.01 [0.93-1.09],0.854688220290561,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL8,Interleukin-8,Inverse variance weighted,8,0.99 [0.9-1.1],0.857903611349839,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSV,Cathepsin L2,Inverse variance weighted,34,1.01 [0.95-1.06],0.858641001720155,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.03 [0.77-1.37],0.858977039096717,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG3,Secretogranin-3,Inverse variance weighted,16,0.99 [0.93-1.07],0.860868654367287,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.03 [0.74-1.44],0.861647824049023,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1.01 [0.92-1.11],0.862090318038427,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.01 [0.86-1.2],0.862679790230506,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REN,Renin,Inverse variance weighted,8,1.02 [0.81-1.28],0.865145759430484,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.98 [0.82-1.19],0.867813252690494,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.01 [0.85-1.21],0.867957505471677,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.01 [0.94-1.08],0.868137761369411,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.97-1.03],0.868716386629304,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.05 [0.57-1.96],0.87031654868098,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.01 [0.89-1.15],0.873236467347228,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.99 [0.91-1.09],0.875612180495784,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.01 [0.93-1.09],0.879556587649996,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGA4,Pepsin A-4,Inverse variance weighted,7,0.99 [0.84-1.16],0.8831977876621,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.93 [0.34-2.55],0.885258519249473,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP6,Gastrotropin,Inverse variance weighted,4,0.97 [0.62-1.51],0.886282477854342,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.99 [0.87-1.13],0.889982124438838,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.98 [0.67-1.41],0.894058538733636,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.97 [0.65-1.46],0.895982036047925,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.01 [0.85-1.21],0.897690697036961,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLF4,Krueppel-like factor 4,Wald ratio,1,0.96 [0.54-1.73],0.899849565559392,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.95 [0.44-2.07],0.900783696642734,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.02 [0.78-1.32],0.901581600767223,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.01 [0.92-1.1],0.901709373530019,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XCL1,Lymphotactin,Inverse variance weighted,15,0.99 [0.88-1.12],0.902019947336629,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1 [0.93-1.09],0.905550203396803,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PKD2,Polycystin-2,Inverse variance weighted,3,0.99 [0.79-1.23],0.906252172462749,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.01 [0.89-1.14],0.907875997775882,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.83-1.24],0.90799224308556,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.99 [0.87-1.13],0.908708846871133,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRELP,Prolargin,Inverse variance weighted,5,0.98 [0.66-1.46],0.910324980241173,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.01 [0.88-1.15],0.912217110468959,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.01 [0.89-1.14],0.912271035312179,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.99 [0.82-1.2],0.914516474451746,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1 [0.97-1.03],0.915172163636824,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.01 [0.82-1.26],0.915460830817361,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.99 [0.85-1.16],0.916379730912242,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSO,Cathepsin O,Inverse variance weighted,19,1 [0.92-1.09],0.91786954333595,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.99 [0.87-1.13],0.918190631494905,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.99 [0.87-1.13],0.918191762005754,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.01 [0.83-1.23],0.919894271735034,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC4,Syndecan-4,Inverse variance weighted,35,1 [0.93-1.08],0.920590860597673,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,0.98 [0.66-1.46],0.921781569550637,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.02 [0.72-1.44],0.922658423631889,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.01 [0.85-1.19],0.92339464406754,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,0.98 [0.65-1.49],0.92345056324914,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FUOM,Fucose mutarotase,Inverse variance weighted,6,0.99 [0.87-1.13],0.925514072507819,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1 [0.91-1.11],0.927678352455344,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN3,Matrilin-3,Inverse variance weighted,4,1.01 [0.89-1.14],0.931019674162026,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP8,Neutrophil collagenase,Inverse variance weighted,10,0.99 [0.85-1.16],0.931604444887262,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNLR1,Interferon lambda receptor 1,Wald ratio,1,0.99 [0.73-1.34],0.932089653925919,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1 [0.9-1.12],0.932340566695656,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.99 [0.8-1.23],0.933839902990431,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FURIN,Furin,Inverse variance weighted,3,1.02 [0.62-1.69],0.934898065342903,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBD,Thrombomodulin,Inverse variance weighted,11,1 [0.93-1.08],0.938102236770857,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGN,Mimecan,Inverse variance weighted,37,1 [0.96-1.04],0.938215409316626,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP3,Stromelysin-1,Inverse variance weighted,4,1.01 [0.81-1.26],0.940694717545502,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1 [0.96-1.04],0.940943474125571,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.99 [0.68-1.44],0.94182385396567,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.99 [0.86-1.15],0.944292031949701,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.01 [0.85-1.19],0.945858430972261,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.01 [0.74-1.38],0.946277957502522,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AREG,Amphiregulin,Inverse variance weighted,5,0.99 [0.82-1.21],0.946724571307654,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.99 [0.82-1.2],0.947838953395537,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RCC1,Regulator of chromosome condensation,Wald ratio,1,0.99 [0.68-1.45],0.954807122600711,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC3B,Tetranectin,Inverse variance weighted,2,1.01 [0.69-1.49],0.955052040866847,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.01 [0.73-1.39],0.957640400189542,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1 [0.89-1.14],0.958204197654535,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1 [0.94-1.06],0.961646046945522,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYBPC2,"Myosin-binding protein C, fast-type",Inverse variance weighted,4,1.01 [0.68-1.49],0.961717443151888,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,0.99 [0.77-1.27],0.96181465422799,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO3,R-spondin-3,Inverse variance weighted,5,1 [0.87-1.16],0.963647846160882,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1 [0.92-1.09],0.965737611961507,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH6,Cadherin-6,Inverse variance weighted,5,1 [0.82-1.21],0.966900914249587,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1 [0.81-1.22],0.969161558118286,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1 [0.87-1.15],0.96930463063949,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,1.01 [0.65-1.57],0.969561784445801,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.81-1.24],0.970011283290437,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1 [0.86-1.15],0.970185231693089,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1 [0.82-1.23],0.97265994540639,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,1 [0.9-1.11],0.973214424170689,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1 [0.85-1.18],0.975379734206995,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1 [0.94-1.06],0.976381489486493,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1 [0.87-1.14],0.976507379395464,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON2,Spondin-2,Inverse variance weighted,3,1 [0.8-1.26],0.979945327936314,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAXX,Protein PAXX,Wald ratio,1,1 [0.82-1.21],0.980457824017214,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS2,Trypsin-2,Inverse variance weighted,17,1 [0.88-1.14],0.983819588458228,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1 [0.87-1.15],0.98389160736755,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1 [0.66-1.51],0.984118908280811,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HHEX,Hematopoietically-expressed homeobox protein HHEX,Wald ratio,1,1 [0.66-1.53],0.984332445829139,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1 [0.66-1.51],0.985444234090235,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1 [0.91-1.1],0.986073261816707,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.99 [0.37-2.64],0.987168388834059,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1 [0.85-1.18],0.988211743639444,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1 [0.88-1.14],0.99459125730526,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1 [0.92-1.08],0.996616633088079,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1 [0.96-1.04],0.996777917643088,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,1 [0.9-1.12],0.996806376448319,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1 [0.86-1.16],0.997230748454567,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1 [0.75-1.34],0.997772604487144,trans
